Neuropsychopharmacology reports.

ISSN 2574-173XJohn Wiley & Sons Inc.United States
ScopusMEDLINEEmbasePubMedPMCSCImagoDOAJMatched via identifier

Journal overview

Journal identity
Titles
Neuropsychopharmacology Reports
Neuropsychopharmacol Rep (abbreviated)
Neuropsychopharmacology reports.
Key identifiers
ISSN
Not available
eISSN
2574-173X
NLM ID
101719700
Publisher / basic metadata
Publisher
John Wiley & Sons Inc.
John Wiley and Sons Inc
Wiley
[Hoboken, NJ] : John Wiley & Sons, Inc., [2018]-
Country
Language
ENG
English

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2018–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

JIF
Not available
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.561
Best Quartile
Q2
H-index
27
Subject categories (quartile varies by category)
  • Clinical Psychology — Q2
  • Pharmacology — Q3
  • Pharmacology (medical) — Q3
  • Psychiatry and Mental Health — Q3
More metrics
Coverage
2018–2026
Country
United States
Region
Northern America
Publisher
John Wiley & Sons Inc.
Open Access
Yes
Open Access (Diamond)
No
Total documents (current year)
110
Total documents (3 years)
260
Total references
4365
Total citations (3 years)
507
Citable documents (3 years)
260
Citations per document (2 years)
2.05
References per document
39.68
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2574-173X
SCImago Source ID
21100862294
SCImago Rank (across all SCImago source types)
10568

Publication activity

Publication activity
SCImago
2025
110 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Open access

DOAJ — Directory of Open Access Journals

Source: DOAJ (Directory of Open Access Journals). Listing status and policy details are reported here as DOAJ published them.

Listed in DOAJ
Yes
License
CC BY, CC BY-NC, CC BY-NC-ND
APC (article processing charge)
2500 USD; 1920 GBP; 2300 EUR
More information
Waiver policy
Yes
Review process
Anonymous peer review
Plagiarism screening
Yes
Preservation services
CLOCKSS, Portico, PMC
Added to DOAJ
2018-08-20
Journal homepage
DOAJ profile
Source details
Match confidence
Probable — one matching ISSN
Matched via ISSN(s)
2574-173X

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Neuropharmacology; Psychopharmacology
Coverage / history
Scopus:2018-2026
MEDLINE:MEDLINE: v38n1, Mar. 2018-In: PubMed: v38n1, Mar. 2018-, PMC;
PubMed:MEDLINE: v38n1, Mar. 2018-In: PubMed: v38n1, Mar. 2018-, PMC;
PMC:v.38(1) 2018 – v.46(3) 2026